Literature DB >> 11418885

Hepatitis C virus infection-related morbidity and mortality among patients with human immunodeficiency virus infection.

H K Monga1, M C Rodriguez-Barradas, K Breaux, K Khattak, C L Troisi, M Velez, B Yoffe.   

Abstract

Hepatitis C virus (HCV) has emerged as a major pathogen among patients with human immunodeficiency virus (HIV). Morbidity and mortality were compared among 263 patients with HIV alone, 166 patients with HIV and HCV, and 60 patients with HCV alone (mean duration of follow-up, 2 years and 10 months). No differences in HIV loads and CD4 cells counts were observed between the HIV and HIV/HCV groups. Alanine aminotransferase levels were higher (52 U/L versus 35 U/L; P<.05) and albumin levels were lower (3.5 g/dL versus 3.8 g/dL; P <.02) among coinfected patients than they were among patients with HIV alone. Liver decompensation developed in 10% of patients with HIV/HCV coinfection. In contrast, no liver-related deaths or decompensation occurred in patients without coinfection (P<.05). Of the patients with HIV alone, 7% died, compared with 11% of the coinfected patients (P<.02); 47% of the deaths in the latter group were due to liver-related causes. In summary, HCV infection causes increased morbidity and mortality in patients with HIV infection.

Entities:  

Mesh:

Year:  2001        PMID: 11418885     DOI: 10.1086/321819

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  65 in total

1.  Coinfection with hepatitis C virus, oxidative stress and antioxidant status in HIV-positive drug users in Miami.

Authors:  M K Baum; S Sales; D T Jayaweera; S Lai; G Bradwin; C Rafie; J B Page; A Campa
Journal:  HIV Med       Date:  2011-02       Impact factor: 3.180

2.  CD56bright NK IL-7Rα expression negatively associates with HCV level, and IL-7-induced NK function is impaired during HCV and HIV infections.

Authors:  Chelsey J Judge; Lenche Kostadinova; Kenneth E Sherman; Adeel A Butt; Yngve Falck-Ytter; Nicholas T Funderburg; Alan L Landay; Michael M Lederman; Scott F Sieg; Johan K Sandberg; Donald D Anthony
Journal:  J Leukoc Biol       Date:  2017-04-11       Impact factor: 4.962

3.  Update on Hepatitis B and C Coinfection in HIV.

Authors:  Patrick Yachimski; Raymond T Chung
Journal:  Curr Infect Dis Rep       Date:  2005-07       Impact factor: 3.725

Review 4.  Analytical and biological variables influencing quantitative hepatitis C virus (HCV) measurement in HIV-HCV coinfection.

Authors:  C L Cooper; Curtis L Cooper; Paul MacPherson; William Cameron
Journal:  Can J Gastroenterol       Date:  2006-01       Impact factor: 3.522

5.  Influence of HCV or HBV coinfection on adverse drug reactions to antiretroviral drugs in HIV patients.

Authors:  Emmanuelle Guitton; Jean-Louis Montastruc; Maryse Lapeyre-Mestre
Journal:  Eur J Clin Pharmacol       Date:  2006-01-17       Impact factor: 2.953

6.  Seroprevalence of hepatitis B and C infection among the HIV-positive population in Abuja, Nigeria.

Authors:  A Tremeau-Bravard; I C Ogbukagu; C J Ticao; J J Abubakar
Journal:  Afr Health Sci       Date:  2012-09       Impact factor: 0.927

7.  Building a Community - Academic Partnership to Enhance Hepatitis C Virus Screening.

Authors:  R Irvin; A McAdams-Mahmoud; D Hickman; J Wilson; W Fenwick; I Chen; N Irvin; O Falade-Nwulia; M Sulkowski; R Chaisson; D L Thomas; S H Mehta
Journal:  J Community Med Health Educ       Date:  2016-05-30

8.  Triple positivity of HBsAg, anti-HCV antibody, and HIV and their influence on CD4+ lymphocyte levels in the highly HIV infected population of Abeokuta, Nigeria.

Authors:  Sandra Olukemi Ogwu-Richard; David Ajiboye Ojo; Olusola Abiodun Akingbade; Iheanyi Omezuruike Okonko
Journal:  Afr Health Sci       Date:  2015-09       Impact factor: 0.927

9.  Evaluation of Drug-Drug Interactions between Direct-Acting Anti-Hepatitis C Virus Combination Regimens and the HIV-1 Antiretroviral Agents Raltegravir, Tenofovir, Emtricitabine, Efavirenz, and Rilpivirine.

Authors:  Amit Khatri; Sandeep Dutta; Martin Dunbar; Thomas Podsadecki; Roger Trinh; Walid Awni; Rajeev Menon
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

10.  Black race as a predictor of poor health outcomes among a national cohort of HIV/AIDS patients admitted to US hospitals: a cohort study.

Authors:  Christine U Oramasionwu; Jonathan M Hunter; Jeff Skinner; Laurajo Ryan; Kenneth A Lawson; Carolyn M Brown; Brittany R Makos; Christopher R Frei
Journal:  BMC Infect Dis       Date:  2009-08-11       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.